Global Neurology Academy

Challenging the Status Quo in Schizophrenia Treatment
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of Schizophrenia
Challenging the Status Quo in Schizophrenia Treatment
- Shelina Ramnarine, PhD
- Stephen Marder, MD
Addressing Social and Systemic Barriers in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
- Shelina Ramnarine, PhD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Nutrition and the Gut-Brain Connection in Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
- Shelina Ramnarine, PhD
- Deanna L. Kelly, PharmD, BCPP
Depression as a Signal of MS Progression
Depression as a Signal of MS Progression
NeuroFrontiers
Depression as a Signal of MS Progression
Advancing Pediatric MS Care: Insights from AAN 2026
Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiers
Advancing Pediatric MS Care: Insights from AAN 2026
- Elizabeth Wilson, MD
Minimal By Design: Define MSE Endpoints
Minimal By Design: Define MSE Endpoints
MinuteCE®
Minimal By Design: Define MSE Endpoints
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Escalate With Intention: Stepwise, Target-Anchored Moves
Escalate With Intention: Stepwise, Target-Anchored Moves
MinuteCE®
Escalate With Intention: Stepwise, Target-Anchored Moves
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Shared Goals, Shared Gains: Align With Patient Preferences
Shared Goals, Shared Gains: Align With Patient Preferences
MinuteCE®
Shared Goals, Shared Gains: Align With Patient Preferences
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit

Medical News

Medical News
Evoke and Evoke+: Oral Semaglutide in Early Alzheimer's Disease
03/24/2026
Read more
Medical News
Microglial Fructose Metabolism and Immune Suppression in Glioblastoma
03/19/2026
Read more
Medical News
GRIN2A Mutation Linked to Impaired Belief Updating in Schizophrenia
03/19/2026
Read more
Medical News
Racial and Biological Diversity in Early Alzheimer Brain Markers
03/16/2026
Read more

See more news

CME/CE

Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
MinuteCE®
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
1.00 program credit
- Christyn Edmundson, MD
1.00 program credit
When to Begin FcRn: Initiation Criteria, Key Evidence
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®
When to Begin FcRn: Initiation Criteria, Key Evidence
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
The IgG Clock: Redose Using IgG Kinetics
The IgG Clock: Redose Using IgG Kinetics
MinuteCE®
The IgG Clock: Redose Using IgG Kinetics
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
The 2-Point Signal: Apply ≥2-Point Rule
The 2-Point Signal: Apply ≥2-Point Rule
MinuteCE®
The 2-Point Signal: Apply ≥2-Point Rule
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit

Clinical Practice

Family Planning in Patients with Multiple Sclerosis
Family Planning in Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning in Patients with Multiple Sclerosis
Strengthening Global Infrastructure for FSHD Trials
Strengthening Global Infrastructure for FSHD Trials
AudioAbstracts
Strengthening Global Infrastructure for FSHD Trials
- Marlene Mimi Maeusli, PhD.
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiers
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
The Burden of Cognitive Dysfunction in Multiple Sclerosis
The Burden of Cognitive Dysfunction in Multiple Sclerosis
NeuroFrontiers
The Burden of Cognitive Dysfunction in Multiple Sclerosis
- Christopher Lock, MD

Programs

The Social Brain in Schizophrenia
The Social Brain in Schizophrenia
On the Frontlines of Schizophrenia
The Social Brain in Schizophrenia
- Shelina Ramnarine, PhD
- Michael Green, PhD
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
1.00 credit 10 episodes
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
FcRn: Same Class, Different Paths—Spot Agent Differentiators
FcRn: Same Class, Different Paths—Spot Agent Differentiators
MinuteCE®
FcRn: Same Class, Different Paths—Spot Agent Differentiators
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Target Locked in gMG: Why T2T Matters
Target Locked in gMG: Why T2T Matters
MinuteCE®
Target Locked in gMG: Why T2T Matters
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit